Larimar Therapeutics, Inc. (LRMR) income statement
LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.14−0.08 (-2.48%)
Close on Nov 20, 2026Market cap $326.19MP/E –Yield –
Larimar Therapeutics, Inc. financial ratios
See a number that looks wrong?